活血定痛方治疗气滞血瘀型早中期膝骨关节炎临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R684.3

基金项目:

广西自然科学基金项目(2021JJA140086)


Clinical Study on Huoxue Dingtong Prescription for Knee Osteoarthritis of Blood Stasis Due to Qi Stagnation Type in Early and Middle Stage
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察活血定痛方治疗气滞血瘀型早、中期膝骨关节炎(KOA) 的临床疗效。方法:选择 早、中期气滞血瘀型KOA 患者120 例,按照随机数字表法分成治疗组与对照组各60 例。对照组予以玻璃酸钠 关节腔注射配合塞来昔布胶囊口服治疗,治疗组在对照组的基础上加用活血定痛方治疗。观察比较2 组临床疗 效,以及治疗前后视觉模拟评分法(VAS)、Lysholm 膝关节评分、疼痛介质[前列腺素E2 (PGE2)、P 物 质(SP)]、促炎因子[白细胞介素-1β (IL-1β)、基质金属蛋白酶-3 (MMP-3)]、抗炎因子[转化生长因 子-β1 蛋白(TGF-β1)、白细胞介素-13(IL-13)]的水平。结果:治疗组临床总有效率为95.00%,对照组为 83.33%,2 组比较,差异有统计学意义(P<0.05)。治疗前,2 组VAS、Lysholm 膝关节评分比较,差异无统 计学意义(P>0.05);治疗后,2 组VAS 评分较治疗前降低(P<0.05)、Lysholm 膝关节评分较治疗前升 高(P<0.05),且治疗组上述2 项评分改善较对照组更显著(P<0.05)。治疗前,2 组PGE2、SP 水平比较, 差异无统计学意义(P>0.05);治疗后,2 组血清PGE2、SP 水平均较治疗前降低(P<0.05),且治疗组 PGE2、SP 水平均低于对照组(P<0.05)。治疗前,2 组血清促炎因子IL-1β、MMP-3 水平比较,差异无统计 学意义(P>0.05);治疗后,2 组IL-1β、MMP-3 水平均较治疗前降低(P<0.05),且治疗组IL-1β、MMP-3 水平均低于对照组(P<0.05)。治疗前,2 组血清TGF-β1、IL-13 水平比较,差异无统计学意义(P> 0.05);治疗后,2 组TGF-β1、IL-13 水平均较治疗前降低(P<0.05),且治疗组TGF-β1、IL-13 水平均低于 对照组(P<0.05)。结论:活血定痛方联合常规西药治疗气滞血瘀型早、中期KOA,可有效减轻患者疼痛症 状,提高膝关节功能,减轻炎症反应。

    Abstract:

    Abstract:Objective:To observe the curative effect of the therapy of Huoxue Dingtong Prescription on knee osteoarthritis(KOA) of blood stasis due to qi stagnation type in early and middle stage. Methods: A total of 120 patients with KOA of blood stasis due to qi stagnation type were selected and divided into the treatment group and the control group according to the random number table methos, with 60 cases in each group. The control group was treated with intra- articular injection with sodium hyaluronate assisting Celecoxib Capsules, and the control group was additionally treated with Huoxue Dingtong Prescription based on the treatment of the control group. The clinical effects and scores of Visual Analogue Scale(VAS), Lysholm scores of knee joints and levels of pain mediators,including prostaglandin E2(PGE2),substance P (SP),proinflammatory factors,including interleukin-1β(IL-1β) and matrix metalloproteinase-3(MMP-3), and anti- inflammatory factors , including transforming growth factor- β1(TGF- β1) and interleukin- 13 (IL- 13), in the two groups before and after treatment were observed and compared. Results: The total clinical effective rate was 95.00% in the treatment group and 83.33% in the control group,the difference being significant(P<0.05). Before treatment, there was no significant difference being found in the comparisons of scores of VAS and Lysholm scores for knee joints between the two groups(P>0.05);after treatment, the scores of VAS in the two groups were decreased when compared with those before treatment(P<0.05), and the Lysholm scores for knee joints were increased(P<0.05), and the improvement in the above two scores in the treatment group was better than that in the control group(P< 0.05). Before treatment, there was no significant difference being found in the comparisons of levels of PGE2 and SP, between the two groups(P>0.05); after treatment, the levels of serum pain mediators, including PGE2 and SP,in the two groups were decreased when compared with those before treatment(P< 0.05),and the levels of PGE2 and SP in the treatment group were lower than those in the control group(P< 0.05). Before treatment, there was no significant difference being found in the comparisons of levels of proinflammatory factors,including IL-1β and MMP-3,between the two groups(P>0.05);after treatment, the levels of IL- 1β and MMP- 3 in the two groups were decreased when compared with those before treatment(P<0.05),and the above two levels in the treatment group were lower than those in the control group(P<0.05). Before treatment, there was no significant difference being found in the comparisons of levels of anti-inflammatory factors,including TGF-β1 and IL-13,between the two groups(P>0.05);after treatment,the levels of TGF-β1 and IL-13 in the two groups were decreased when compared with those before treatment(P<0.05),and the above two levels in the treatment group were lower than those in the control group(P<0.05). Conclusion: The therapy of Huoxue Dingtong Prescription combined with routine western medicine can effectively alleviate the pain of patients with KOA of blood stasis due to qi stagnation type in early and middle stage,enhance the knee joint function,and reduce the inflammatory responses.

    参考文献
    相似文献
    引证文献
引用本文

李朋,梁祥翰,陈德俊,罗天,李钊.活血定痛方治疗气滞血瘀型早中期膝骨关节炎临床研究[J].新中医,2022,54(24):111-115

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-01-01
  • 出版日期:
文章二维码